A bioinformatics and meta-analysis study indicates that the overexpression of SNHG5 is associated with poor prognosis in various cancers, including colorectal cancer and AML (Pashirzad and Sahebkar, 2024). Furthermore, multiple studies have experimentally confirmed that SNHG5 is involved in cell proliferation, apoptosis, and chemotherapy resistance in AML (Li and Sun, 2018; Priya et al., 2024). This evidence concerns the gene SNHG5 and acute myeloid leukemia.